ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015
Germline BRCA1/2 Mutations: Are They Good Enough to Determine Who Will Respond to Poly(ADP-Ribose) Polymerase Inhibitor Therapy in Advanced Cancer?
Mehmet S Copur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.